C4 Therapeutics ( ($CCCC) ) has shared an update. On October 16, 2025, C4 Therapeutics announced an underwritten offering of common stock and ...

Concurrent with the proposed public offering, Lexeo intends to sell shares of its common stock, and, in lieu of common stock, pre-funded warrants to purchase shares of its common stock, to Balyasny ...

Canaccord Genuity is acting as the sole bookrunner for the offering. Roth Capital Partners is acting as co-manager for the offering.

Quantum computing firm IonQ announces a $2.0 billion equity offering. Jim Cramer explains why the deal makes IONQ stock 'very ...

Ondas Holdings (ONDS) has priced its $425 million underwritten offering of 19,560,000 shares of its common stock and, in lieu of common stock, pre-funded warrants to purchase up to 17,400,000 shares ...

Hyperfine (HYPR) announced that it has commenced an underwritten public offering of its Class A common stock or, in lieu of Class A common stock ...

We recently published Jim Cramer Discussed These 11 Stocks & The Market’s 3rd Bull Run Anniversary. IonQ, Inc. (NYSE:IONQ) is ...

Envoy Medical (NASDAQ:COCH) has announced it has entered into definitive agreements for a new capital raise, for issuance and sell an aggregate of 3,007,524 shares of Class A common stock in a ...

Dragonfly Energy shares were 30% lower, at $1.38, after the company priced an underwritten public offering of 36 million shares at $1.35 a share and prefunded warrants to buy up to 5 million shares at ...

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders ...

Investing.com -- Lexeo Therapeutics Inc (NASDAQ:LXEO) stock dropped 4.7% in after-hours trading Thursday following the company’s announcement of a proposed public offering and concurrent private ...